What Type of Drug OxyContin Is ? When It Was First Introduced? Is It a Schedule Controlled Drug?

Question by Islam: What type of drug OxyContin is ? When it was first introduced? Is it a schedule controlled drug?
OxyContin®, commonly known on the street as OC, OX, Oxy, Oxycotton, Hillbilly heroin, and kicker, led to a marked escalation of its abuse as reported by drug abuse treatment centers, law enforcement personnel, and health care professionals.

Best answer:

Answer by ckm1956
1) long acting narcotic
2) 1996
3) Schedule II narcotic

Know better? Leave your own answer in the comments!

Louisiana Drug Rehab Centers – Townsend presents on How Medicine Can Help Addiction – http://townsendla.com/ Louisiana Drug Rehab Centers – Townsend’s Dr Wetsman presents on How Medicine Can Help Addiction.

Conference says state needs to get better at mental health issues

Filed under: drug abuse help centers

He also said that the correlation of mental illness, substance abuse and homelessness speaks to the need for a system that can address each of those issues. He said a “housing-first” approach is a must. The teleconference began with a … Panelist Jane …
Read more on Mohave Valley News

HEALTH REFORM: Many on Medicare Already Enjoying Benefits

Filed under: drug abuse help centers

Joe Baker, president of the Medicare Rights Center, in New York City, which helps people on Medicare and their caregivers understand their options, counts the closing of the "donut hole" in Medicare's prescription drug benefit and the addition of free …
Read more on HealthDay

Beer and marijuana now more potent

Filed under: drug abuse help centers

… Ripley and Dearborn counties were financially supported by the Ripley County Local Coordinating Council, Indiana Youth Institute, Dearborn County Citizens Against Substance Abuse and One Community One Family of Community Mental Health Center.
Read more on Batesville Herald Tribune

Penn State College of Medicine Receives Grant to Fund Tobacco Research

Filed under: drug abuse help centers

This $ 20 million, five-year U.S. Food and Drug Administration/National Institutes of Health grant will fund research to help the FDA develop new and effective regulatory strategies for reducing the harm to health from tobacco products in the United …
Read more on Gant Daily